Clinical Trial Update: Anakinra in Dengue With Hyperinflammation ( AnaDen ) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the anti-inflammatory drug anakinra for dengue patients with hyperinflammation; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Oxford University Clinical Research Unit, Vietnam | Conditions: Dengue, Dengue With Warning Signs | Phase 2 | Status: ACTIVE_NOT_RECRUITING